id
stringlengths 7
12
| summary
stringlengths 86
226k
| topic
stringclasses 21
values | subtopic
stringclasses 114
values | subjects_top_term
stringclasses 34
values | date
stringlengths 8
10
| text
stringlengths 59
90.8k
|
|---|---|---|---|---|---|---|
110-HR-4 | Medicare Prescription Drug Price Negotiation Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to prescription drug plan sponsors and Medicare Advantage organizations for covered part D drugs for part D eligible individuals enrolled under a prescription drug plan or under a Medicare Advantage prescription drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2007-01-05 | medicare prescription drug price negotiation act amends title xviii medicare social security act require secretary health_and_human_services negotiate pharmaceutical manufacturers prices charged prescription drug plan sponsors medicare_advantage organizations covered drugs eligible individuals enrolled prescription drug plan medicare_advantage prescription drug ma-pd plan |
110-HR-118 | Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate with drug manufacturers and pharmacies prices charged to prescription drug plan (PDP) sponsors and Medicare Advantage organizations for covered part D drugs provided under Medicare. | Health | Drug Coverage and Cost | Health | 2007-01-04 | amends voluntary prescription drug benefit program title xviii medicare social security act authorize secretary health_and_human_services negotiate drug manufacturers pharmacies prices charged prescription drug plan pdp sponsors medicare_advantage organizations covered drugs provided medicare |
110-HR-205 | Medicare Prescription Drug Enrollment Extension Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to extend the annual enrollment periods of the Medicare and Medicare Advantage prescription drug benefit programs. | Health | Drug Coverage and Cost | Health | 2007-01-04 | amends title xviii medicare social security act extend annual enrollment periods medicare medicare_advantage prescription drug benefit programs |
110-HR-426 | Medicaid Obesity Treatment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to require Medicaid drug coverage of drugs prescribed for treatment of obesity. | Health | Drug Coverage and Cost | Health | 2007-01-11 | treatment act amends title xix medicaid social security act require medicaid drug coverage drugs prescribed treatment obesity |
110-HR-464 | Compassionate Assistance for Rape Emergencies Act of 2007 - Prohibits any federal funds from being provided to a hospital under title XVIII (Medicare) of the Social Security Act or to a state, with respect to hospital services, under title XIX (Medicaid) of such Act, unless the hospital meets certain conditions related to a woman who is a victim of sexual assault, including that the hospital: (1) provides the woman with accurate and unbiased information about emergency contraception; (2) offers emergency contraception to the woman; (3) provides the woman such contraception at the hospital on her request; and (4) does not deny any such services because of the inability of the woman or her family to pay. | Health | Drug Coverage and Cost | Health | 2007-01-12 | compassionate assistance rape emergencies act prohibits federal funds provided hospital title xviii medicare social security act state respect hospital services title xix medicaid act hospital meets certain conditions related woman victim sexual assault including hospital provides woman accurate unbiased information emergency contraception offers emergency contraception woman provides woman contraception hospital request deny services inability woman family pay |
110-HR-470 | Amends part D (Voluntary Prescription Drug Benefit Program ) of title XVIII (Medicare) of the Social Security Act (SSA) to provide for continuity of coverage of prescription drugs under Medicare prescription drug plans for full-benefit dual eligible individuals.Provides for Medicare prescription drug coverage of benzodiazepines and of off-label uses of prescription drugs and biologicals.Amends SSA title XIX (Medicaid) to permit state Medicaid programs to cover Medicare prescription drug copayments for full-benefit dual eligible individuals.Amends SSA title XVIII to authorize the Secretary of Health and Human Services to waive denial of Medicare prescription drug coverage. | Health | Drug Coverage and Cost | Health | 2007-01-12 | amends voluntary prescription drug benefit program title xviii medicare social security act ssa provide continuity coverage prescription drugs medicare prescription drug plans benefit dual eligible individuals provides medicare prescription drug coverage benzodiazepines label uses prescription drugs biologicals amends ssa title xix medicaid permit state medicaid programs cover medicare prescription drug copayments benefit dual eligible individuals amends ssa title xviii authorize secretary health_and_human_services waive denial medicare prescription drug coverage |
110-HR-932 | Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to limit to $10, adjusted for inflation, the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals (eligible for both part D and Medicaid under SSA title XIX) and other lowest-income individuals. | Health | Drug Coverage and Cost | Health | 2007-02-08 | amends voluntary prescription drug benefit program title xviii medicare social security act ssa limit adjusted inflation monthly prescription drug cost sharing benefit dual eligible individuals eligible medicaid ssa title xix lowest income individuals |
110-HR-1218 | Medicare Prescription Drug Improvement Act - Amends title XVIII (Medicare) of the Social Security Act to repeal provisions prohibiting the Secretary of Health and Human Services from interfering with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Grants the Secretary authority similar to that of the Secretary of Veterans Affairs, Secretary of Defense, and the heads of other Federal agencies and departments that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered Medicare part D (Voluntary Prescription Drug Benefit Program) drugs.Eliminates the initial coverage limit on the maximum costs that may be recognized for payment purposes (including the annual deductible) with respect to prescription drug benefits. Pharmaceutical Market Access Act of 2007 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law. Amends such restored law to direct the Secretary to promulgate regulations allowing qualifying individuals (in addition to pharmacists and wholesalers) to import covered products. Repeals the mandate that the Secretary require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received. Amends provisions regarding the testing of imported covered products. Declares that specified tests shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer-wholesaler unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging. Directs the Secretary to require that the packaging of any subject drug incorporate specified overt optically variable counterfeit-resistant technologies. | Health | Drug Coverage and Cost | Health | 2007-02-27 | title xviii medicare social security act repeal provisions prohibiting secretary health_and_human_services interfering negotiations drug manufacturers pharmacies prescription drug plan sponsors grants secretary authority similar secretary veterans_affairs secretary defense heads federal agencies departments purchase prescription drugs bulk negotiate contracts manufacturers covered medicare voluntary prescription drug benefit program drugs eliminates initial coverage limit maximum costs recognized payment purposes including annual deductible respect prescription drug benefits pharmaceutical market access act amends repeal certain sections medicare_prescription_drug improvement modernization act relating importation prescription drugs canada restore previous law amends restored law direct secretary promulgate regulations allowing qualifying individuals addition pharmacists wholesalers import covered products repeals mandate secretary require foreign seller specify original source product lot product originally received amends provisions testing imported covered products declares specified tests shall required importer wholesaler requires tests conducted importer wholesaler product prescription drug subject provisions act pertaining counterfeit resistant packaging classifies prescription drugs misbranded incorporate specified counterfeit resistant technologies packaging directs secretary require packaging subject drug incorporate specified variable counterfeit resistant technologies |
110-HR-1277 | Medicare Prescription Drug Benefits Gap Elimination Act of 2007 - Directs the Secretary of Health and Human Services to study and report to Congress on how to eliminate the gap in benefits for covered part D drugs under the Medicare prescription drug program under Medicare part D (Voluntary Prescription Drug Benefit Program) of title XVIII of the Social Security Act after a part D eligible individual's costs exceed the initial coverage limit, and before the individual obtains protection against high out-of-pocket expenditures. | Health | Drug Coverage and Cost | Health | 2007-03-01 | medicare prescription drug benefits gap elimination act directs secretary health_and_human_services study report congress eliminate gap benefits covered drugs medicare prescription drug program medicare voluntary prescription drug benefit program title xviii social security act eligible individual costs exceed initial coverage limit individual obtains protection high pocket expenditures |
110-HR-1536 | Prescription Coverage Now Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Service to provide for an expedited process for the qualification for low-income assistance through a request to the Secretary of the Treasury for tax return and other information sufficient to identify: (1) whether the individual involved is likely eligible for subsidies; and (2) the amount of premium and cost-sharing subsidies for which they would qualify based on such information. Provides for modification of resource standards for determination of eligibility for low-income subsidy and revision of income and asset rules. Requires indexing of deductibles and cost-sharing above the annual out-of-pocket threshold for individuals with income below 150% of the poverty line. Requires screening by the Commissioner of Social Security for eligibility under Medicare savings programs.Creates a special enrollment period for subsidy eligible individuals. Waives the late enrollment penalty for subsidy eligible individuals. | Health | Drug Coverage and Cost | Health | 2007-03-15 | prescription coverage act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_service provide expedited process qualification low income assistance request secretary treasury tax return information sufficient identify individual involved likely eligible subsidies premium cost sharing subsidies qualify based information provides modification resource standards determination eligibility low income subsidy revision income asset rules requires indexing deductibles cost sharing annual pocket threshold individuals income poverty line requires screening commissioner_of_social_security eligibility medicare savings programs creates special enrollment period subsidy eligible individuals waives late enrollment penalty subsidy eligible individuals |
110-HR-2056 | Medicare Part D Improvement Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of the Social Security Act to revise requirements for the Medicare prescription drug program with respect to: (1) counting certain expenditures towards out-of-pocket limits; (2) conforming the late enrollment penalty to the Medicare part B penalty structure; (3) allowing more frequent changes in plans; and (4) removing the asset test and eliminating late enrollment penalties for low-income subsidy eligible individuals. Directs the Secretary of Health and Human Services to study and report to Congress on how to: (1) eliminate the gap in Medicare part D prescription drug coverage created through the application of an initial coverage limit; and (2) finance such elimination. | Health | Drug Coverage and Cost | Health | 2007-04-26 | medicare improvement act amends voluntary prescription drug benefit program social security act revise requirements medicare prescription drug program respect counting certain expenditures pocket limits conforming late enrollment penalty medicare penalty structure allowing frequent changes plans removing asset test eliminating late enrollment penalties low income subsidy eligible individuals directs secretary health_and_human_services study report congress eliminate gap medicare prescription drug coverage created application initial coverage limit finance elimination |
110-HR-2065 | Medicare Drug Savings Through Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) offer a Medicare operated prescription drug plan with a service area that consists of the entire United States; (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered Medicare part D drugs; and (3) encourage the use of more affordable therapeutic equivalents. Requires the monthly beneficiary premium charged under such a plan to be uniform nationally. Requires adjustment of such premium amount in case of supplemental prescription drug coverage. | Health | Drug Coverage and Cost | Health | 2007-04-26 | amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services offer medicare operated prescription drug plan service area consists entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered medicare drugs encourage use affordable therapeutic equivalents requires monthly beneficiary premium charged plan uniform nationally requires adjustment premium case supplemental prescription drug coverage |
110-HR-2412 | Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to prohibit a group health plan, and a health insurance issuer providing group coverage, from: (1) excluding or restricting benefits for prescription contraceptive drugs, devices, and outpatient services if the plan provides benefits for other outpatient prescription drugs, devices, or outpatient services; (2) denying eligibility based on use or potential use of such items or services; (3) providing monetary payments or rebates to a covered individual to encourage acceptance of less than the minimum protections available; (4) penalizing, reducing, or limiting a professional's reimbursement because the professional prescribed such drugs or devices or provided such services; or (5) providing incentives to a professional to induce the professional to withhold such drugs, devices, or services. Applies such prohibitions to coverage offered in the individual market. | Health | Drug Coverage and Cost | Health | 2007-05-21 | equity prescription insurance contraceptive coverage act amends employee retirement income security act erisa public_health_service_act prohibit group health plan health insurance issuer providing group coverage excluding restricting benefits prescription contraceptive drugs devices outpatient services plan provides benefits outpatient prescription drugs devices outpatient services denying eligibility based use potential use items services providing monetary payments rebates covered individual encourage acceptance minimum protections available penalizing reducing limiting professional reimbursement professional prescribed drugs devices provided services providing incentives professional induce professional withhold drugs devices services applies prohibitions coverage offered individual market |
110-HR-2875 | Medicare Residency Program Technical Correction Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act with respect to payments to hospitals for the direct graduate medical education (DGME) costs of inpatient hospital services, particularly the redistribution among qualifying hospitals of unused resident positions which figure in the calculation of DGME costs.Requires a specified adjustment to the reduction of Medicare resident positions where that reduction was based on a cost report subsequently settled, whether as a result of an appeal or otherwise, if the reference resident level under such settled cost report is higher than the resident level used for the reduction. | Health | Drug Coverage and Cost | Health | 2007-06-27 | amends title xviii medicare social security act respect payments hospitals direct graduate medical education costs inpatient hospital services particularly redistribution qualifying hospitals unused resident positions figure calculation costs requires specified adjustment reduction medicare resident positions reduction based cost report subsequently settled result appeal reference resident level settled cost report higher resident level reduction |
110-HR-3025 | Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to: (1) offer one or more Medicare operated prescription drug plans (PDPs) with a service area consisting of the entire United States; and (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered part D drugs. Requires the monthly beneficiary premium for qualified prescription drug coverage and access to negotiated prices to be uniform nationally. Provides for auto-enrollment of subsidy eligible individuals in Medicare operated PDPs.Amends SSA title XIX (Medicaid) to provide for the use of 2005 as base in computing the state clawback provision. Amends SSA title XVIII (Medicare) to eliminate part D cost-sharing for certain non-institutionalized full-benefit dual eligible individuals. Provides for: (1) expedited low-income subsidies under the Medicare PDP; (2) indexing of deductible and cost-sharing for certain individuals; and (3) Commissioner of Social Security screening for Medicare savings program eligibility. Sets forth anti-fraud and abuse provisions. Provides for protection against a decrease in Social Security benefits owing to part D Medicare premium increases. Prohibits late enrollment penalties for months before January 2008. Allows a one-time change in plan during first year of enrollment. Prohibits a PDP sponsor from removing a covered part D drug from the plan formulary, downgrading its cost-sharing status, or otherwise introducing a barrier to access to covered part D drugs, without advance notice. Requires Medicare part D formularies to cover all drugs in six specified therapeutic categories. Makes benzodiazepines covered part D drugs, subject to review by the Secretary. Eliminates the MA Regional Stabilization Fund and certain Medicare Advantage overpayments.Requires prompt payment of clean claims by Medicare and Medicare Advantage PDPs. Prohibits co-branding. Extends part D coverage to medication therapy management services. | Health | Drug Coverage and Cost | Health | 2007-07-12 | act amends voluntary prescription drug benefit program title xviii medicare social security act ssa direct secretary health_and_human_services offer medicare operated prescription drug plans pdps service area consisting entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered drugs requires monthly beneficiary premium qualified prescription drug coverage access negotiated prices uniform nationally provides auto enrollment subsidy eligible individuals medicare operated pdps amends ssa title xix medicaid provide use base computing state provision amends ssa title xviii medicare eliminate cost sharing certain non institutionalized benefit dual eligible individuals provides expedited low income subsidies medicare pdp indexing deductible cost sharing certain individuals commissioner social_security screening medicare savings program eligibility sets forth anti fraud abuse provisions provides protection decrease social_security benefits owing medicare premium increases prohibits late enrollment penalties months january allows time change plan year enrollment prohibits pdp sponsor removing covered drug plan formulary cost sharing status introducing barrier access covered drugs advance notice requires medicare formularies cover drugs specified therapeutic categories makes benzodiazepines covered drugs subject review secretary eliminates certain medicare_advantage overpayments requires prompt payment clean claims medicare medicare_advantage pdps prohibits branding extends coverage medication therapy management services |
110-HR-3041 | Medicaid Prescription Drug Rebate Equalization Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending to such organizations the discounts offered under fee-for-service Medicaid plans.Requires the state contract with a Medicaid managed care organization to provide that: (1) payment for covered outpatient drugs dispensed to Medicaid-eligible individuals enrolled with the organization shall be subject to the same rebate as the state is subject to; and (2) the state shall allow the organization to collect such rebates from manufacturers.Requires also that capitation rates paid to the organization be: (1) based on actual cost experience related to rebates; and (2) subject to the federal regulations requiring actuarially sound rates. | Health | Drug Coverage and Cost | Health | 2007-07-12 | amends title xix medicaid social security act reduce costs prescription drugs enrollees medicaid managed care organizations extending organizations discounts offered fee service medicaid plans requires state contract medicaid managed care organization provide payment covered outpatient drugs dispensed medicaid eligible individuals enrolled organization shall subject rebate state subject state shall allow organization collect rebates manufacturers requires capitation rates paid organization based actual cost experience related rebates subject federal regulations requiring actuarially sound rates |
110-HR-3061 | Medicare Part D Drug Class Protection Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in six specified therapeutic categories. Sets forth special requirements for reconsideration of coverage determinations, and appeals for drugs included in such categories. Establishes reporting requirements for drugs in these categories. | Health | Drug Coverage and Cost | Health | 2007-07-17 | medicare drug class protection act amends voluntary prescription drug benefit program title xviii medicare social security act require medicare prescription drug plans formularies cover drugs included specified therapeutic categories sets forth special requirements reconsideration coverage determinations appeals drugs included categories establishes reporting requirements drugs categories |
110-HR-3090 | Patient and Pharmacy Protection Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act, as amended by the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007, to limit to Controlled Substances Act schedule II narcotics the use of tamper-resistant prescription pads required under the Medicaid program for payment of amounts expended for covered outpatient drugs. | Health | Drug Coverage and Cost | Health | 2007-07-18 | patient pharmacy protection act amends title xix medicaid social security act amended katrina_recovery iraq_accountability_appropriations_act limit controlled substances act schedule narcotics use tamper resistant prescription pads required medicaid program payment amounts expended covered outpatient drugs |
110-HR-3140 | Saving Our Community Pharmacies Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to provide for: (1) use of median retail acquisition cost as the basis for Medicaid reimbursement limits on generic drugs; and (2) establishment of an evidence-based prescription drug program. Directs the Comptroller General to study and report to Congress on the costs of community retail pharmacies to dispense prescription drugs. | Health | Drug Coverage and Cost | Health | 2007-07-24 | saving community pharmacies act amends title xix medicaid social security act provide use median retail acquisition cost basis medicaid reimbursement limits generic drugs establishment evidence based prescription drug program directs comptroller_general study report congress costs community retail pharmacies dispense prescription drugs |
110-HR-3193 | Access to Community Pharmacy Preservation Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require states to pay dispensing fees for Medicaid covered outpatient drugs. Directs a state which provides medical assistance for covered outpatient drugs to establish a minimum Medicaid dispensing fee of at least $8 per unit for covered outpatient multiple source drugs. Revises the requirement for application of the federal upper pharmacy reimbursement limit in the calculation of the payment for covered outpatient drugs. Increases from 250% to 300% the percentage of the average manufacturer price (AMP) the Secretary of Health and Human Services is required to substitute for 150% of the published price. Repeals the state option to increase the cap on the equity asset test for an individual's eligibility for long-term care assistance under Medicaid. Directs the Secretary, for purposes of verifying financial eligibility for Medicaid, to collaborate with the Commissioner of Social Security for use of the Commissioner's system for obtaining information held by financial institutions in order to verify eligibility for benefits under SSA title VI (Supplemental Security Income) (SSI). | Health | Drug Coverage and Cost | Health | 2007-07-26 | amends title xix medicaid social security act ssa require states pay dispensing fees medicaid covered outpatient drugs directs state provides medical assistance covered outpatient drugs establish minimum medicaid dispensing fee unit covered outpatient multiple source drugs revises requirement application federal upper pharmacy reimbursement limit calculation payment covered outpatient drugs increases percentage average manufacturer price secretary health_and_human_services required substitute published price repeals state option increase cap equity asset test individual eligibility long term care assistance medicaid directs secretary purposes verifying financial eligibility medicaid collaborate commissioner_of_social_security use commissioner system obtaining information held financial institutions order verify eligibility benefits ssa title ssi |
110-HR-3282 | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B. Makes him or her responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients. | Health | Drug Coverage and Cost | Health | 2007-08-01 | comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients |
110-HR-3700 | Fair Medicaid Drug Payment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to direct the Secretary of Health and Human Services to calculate the federal upper reimbursement limit as no less than 300% of the weighted average (based on utilization) of the most recent average manufacturer prices (AMPs) for pharmaceutically and therapeutically equivalent multiple source drug products available for purchase by retail community pharmacies on a nationwide basis. Directs the Secretary to implement a smoothing process for AMPs to ensure that federal upper reimbursement limits do not vary significantly from month to month as a result of rebates, discounts, and other pricing practices. Requires a state plan to subject to prior authorization all covered outpatient drug products that are innovator multiple source drugs, if such drug products are more expensive than other biologically and therapeutically equivalent drug products available for purchase in that state by retail community pharmacies. Revises requirements for monthly reports to the Secretary of price information by manufacturers subject to rebate agreements. | Health | Drug Coverage and Cost | Health | 2007-09-27 | fair medicaid drug payment act amends title xix medicaid social security act direct secretary health_and_human_services calculate federal upper reimbursement limit weighted average based utilization recent average manufacturer prices amps therapeutically equivalent multiple source drug products available purchase retail community pharmacies nationwide basis directs secretary implement process amps ensure federal upper reimbursement limits vary significantly month month result rebates discounts pricing practices requires state plan subject prior authorization covered outpatient drug products innovator multiple source drugs drug products expensive biologically therapeutically equivalent drug products available purchase state retail community pharmacies revises requirements monthly reports secretary price information manufacturers subject rebate agreements |
110-HR-3932 | Medicare Prescription Drug Savings and Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan; and (3) pharmacy payments under such a plan. | Health | Drug Coverage and Cost | Health | 2007-10-23 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan pharmacy payments plan |
110-HR-4054 | Prevention Through Affordable Access Act - Amends title XIX (Medicaid) of the Social Security Act to revise requirements for the best price component of the formula for determination of the Medicaid rebate for a covered single source outpatient drug or a covered innovator multiple source outpatient drug. (Under current law, best prices shall not take into account prices that are merely nominal in amount.) Revises the list of entities to which sales by a manufacturer of covered outpatient drugs at nominal prices shall be considered to be sales at a nominal price, or merely nominal in amount (and thus excluded from computation of the best price for such drugs). Adds to such list any entity that is: (1) operated by a health center of an institution of higher education, primarily for its students (university-based clinic); or (2) a public or private nonprofit entity that provides family planning services under the Public Health Service Act (safety-net clinic). | Health | Drug Coverage and Cost | Health | 2007-11-01 | prevention affordable access act amends title xix medicaid social security act revise requirements best price component formula determination medicaid rebate covered single source outpatient drug covered innovator multiple source outpatient drug current law best prices shall account prices merely nominal revises list entities sales manufacturer covered outpatient drugs nominal prices shall considered sales nominal price merely nominal excluded computation best price drugs adds list entity operated health center institution higher education primarily students university based clinic public private nonprofit entity provides family planning services public_health_service_act safety net clinic |
110-HR-4263 | Health Insurance Tax Credit Assistance Act of 2007 - Amends the Internal Revenue Code to allow a tax credit for charitable contributions to tax-exempt charities which subsidize health insurance premiums and pharmacy co-payments of uninsured individuals or individuals who cannot otherwise afford health insurance or drug treatments. | Health | Drug Coverage and Cost | Taxation | 2007-12-04 | amends internal revenue code allow tax credit charitable contributions tax exempt charities subsidize health insurance premiums pharmacy payments uninsured individuals individuals afford health insurance drug treatments |
110-HR-4295 | Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2008, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula. | Health | Drug Coverage and Cost | Health | 2007-12-05 | reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula |
110-HR-4296 | Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to: (1) make incentive payments for physician use of an electronic prescription drug program (E-prescribing); and (2) reduce by 10% the fee schedule amount for failure to use E-prescribing. Directs the Administrator of the Centers for Medicare & Medicaid Services to report to Congress on progress on implementing E-prescribing under the Medicare electronic prescription drug program. | Health | Drug Coverage and Cost | Health | 2007-12-05 | meds act amends title xviii medicare social security act require secretary health_and_human_services incentive payments physician use electronic prescription drug program prescribing reduce fee schedule failure use prescribing directs administrator centers report congress progress implementing prescribing medicare electronic prescription drug program |
110-HR-4330 | Amends title XVIII (Medicare) of the Social Security Act to repeal the income-related increase in Medicare part B (Supplementary Medical Insurance) premiums that was enacted as part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, as amended by the Deficit Reduction Act of 2005. | Health | Drug Coverage and Cost | Health | 2007-12-06 | amends title xviii medicare social security act repeal income related increase medicare supplementary_medical_insurance premiums enacted medicare_prescription_drug improvement modernization act amended deficit reduction act |
110-HR-5317 | Medicare Prescription Drug Affordability Act of 2008 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to: (1) limit Medicare part D prescription drug plan (PDP) cost increases to the Social Security cost-of-living increase; and (2) direct the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to PDP sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2008-02-07 | amends voluntary prescription drug benefit program title xviii medicare social security act limit medicare prescription drug plan pdp cost increases social_security cost living increase direct secretary health_and_human_services negotiate pharmaceutical manufacturers prices charged pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan |
110-HR-6684 | Medicare Prescription Drug Cost Equalization Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to: (1) require application to specialty tier drugs (very high cost and unique items) of the process for exception from the tiered cost-sharing for drugs included within a formulary; and (2) limit to 25% the Medicare cost-sharing for such specialty tier drugs. (Under an exception, a nonpreferred drug could be covered under the terms applicable for preferred drugs if the prescribing physician determines that the preferred drug for treatment of the same condition either would not be as effective for the individual, or would have adverse effects for the individual, or both. ) | Health | Drug Coverage and Cost | Health | 2008-07-31 | voluntary prescription drug benefit program title xviii medicare social security act require application specialty tier drugs high cost unique items process exception tiered cost sharing drugs included formulary limit medicare cost sharing specialty tier drugs exception drug covered terms applicable preferred drugs prescribing physician determines preferred drug treatment condition effective individual adverse effects individual |
110-HR-6800 | Medicare Drugs for Seniors (MEDS) Act of 2008 -Amends title XVIII (Medicare) of the Social Security Act to replace the current part D (Voluntary Prescription Drug Benefit Program) program, adopted by the Medicare Prescription Drug, Improvement and Modernization Act of 2003, with a revised prescription drug benefit program under a new part D (Prescription Medicine Benefit for the Aged and Disabled) for all Medicare beneficiaries. Provides for reductions in the price of prescription drugs for Medicare beneficiaries. Amends the Federal Food, Drug, and Cosmetic Act to: (1) revise requirements with respect to the commercial and personal importation of prescription drugs and the disposition of certain drugs denied admission; and (2) prescribe requirements with respect to Internet sales of prescription drugs. Provides that if any federal agency or any non-profit entity undertakes federally funded health care research and development, and is to convey or provide a patent or other exclusive right to use such research and development for a drug or other health care technology, such agency or entity shall not make such conveyance or provide such patent or other right until the recipient first agrees to a reasonable pricing agreement with the Secretary of Health and Human Services, or the Secretary determines that the public interest is served by a waiver of the reasonable pricing agreement. Sets forth Medigap transition requirements. | Health | Drug Coverage and Cost | Health | 2008-08-01 | seniors meds act title xviii medicare social security act replace current voluntary prescription drug benefit program program adopted revised prescription drug benefit program new prescription medicine benefit aged disabled medicare beneficiaries provides reductions price prescription drugs medicare beneficiaries amends cosmetic act revise requirements respect commercial personal importation prescription drugs disposition certain drugs denied admission prescribe requirements respect internet sales prescription drugs provides federal agency non profit entity federally funded health care research development convey provide patent exclusive right use research development drug health care technology agency entity shall conveyance provide patent right recipient agrees reasonable pricing agreement secretary health_and_human_services secretary determines public interest served waiver reasonable pricing agreement sets forth medigap transition requirements |
110-S-3 | Medicare Prescription Drug Price Negotiation Act of 2007 - Expresses the sense of Congress that Congress should enact, and the President should sign, legislation to amend part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for fair prescription drug prices for Medicare beneficiaries. | Health | Drug Coverage and Cost | Health | 2007-01-04 | medicare prescription drug price negotiation act expresses sense congress congress enact president sign legislation amend voluntary prescription drug benefit program title xviii medicare social security act provide fair prescription drug prices medicare beneficiaries |
110-S-28 | Generics First Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to exclude from coverage under the Medicare part D prescription drug program all nongeneric (brand name) drugs unless no generic drug has been approved, and the brand name drug is determined to be medically necessary. | Health | Drug Coverage and Cost | Health | 2007-01-04 | amends voluntary prescription drug benefit program title xviii medicare social security act exclude coverage medicare prescription drug program brand drugs generic drug approved brand drug determined medically necessary |
110-S-250 | Medicare Enhancements for Needed Drugs Act of 2007 - Directs the Comptroller General to review and report to Congress on the retail cost of prescription drugs in the United States during 2000 through 2006, with an emphasis on the prescription drugs most utilized for individuals age 65 or older.Requires the Comptroller General to conduct an ongoing study that compares the average retail cost in the United States for each of the 20 most utilized prescription drugs for individuals age 65 or older with: (1) the average prices at which private health plans, the Department of Defense under the Defense Health Program, and the Department of Veterans Affairs acquire each such drug; and (2) the average negotiated price for each such drug that eligible beneficiaries have access to under a Medicare prescription drug plan providing only basic prescription drug coverage.Amends title XVIII (Medicare) of the Social Security Act (SSA) to include in the comparative plan information for beneficiaries under new Medicare part D (Voluntary Prescription Drug Benefit Program) a comparison of average aggregate prescription drug plan beneficiary costs and savings with such costs for a beneficiary with no prescription drug plan. Repeals the prohibition against interference by the Secretary of Health and Human Services with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Authorizes the Secretary instead, like other federal entities that purchase prescription drugs in bulk, to negotiate contracts with manufacturers of covered part D drugs. Requires the savings to the Medicare Prescription Drug Account through the use of authority provided under this Act to be used to strengthen the part D program and to reduce the federal deficit. Requires the Secretary to ensure that each part D eligible individual has: (1) a choice of enrollment in a comprehensive prescription drug plan in the area in which the individual resides; or (2) in any case in which such a plan is not available, the opportunity to enroll in a comprehensive fallback prescription drug plan. | Health | Drug Coverage and Cost | Health | 2007-01-10 | needed drugs act directs comptroller general review report congress retail cost prescription drugs united_states emphasis prescription drugs utilized individuals age older requires comptroller general conduct ongoing study compares average retail cost united_states utilized prescription drugs individuals age older average prices private health plans department_of_defense defense_health_program department_of_veterans_affairs acquire drug average negotiated price drug eligible beneficiaries access medicare prescription drug plan providing basic prescription drug coverage amends title xviii medicare social security act ssa include comparative plan information beneficiaries new medicare voluntary prescription drug benefit program comparison average aggregate prescription drug plan beneficiary costs savings costs beneficiary prescription drug plan repeals prohibition interference secretary health_and_human_services negotiations drug manufacturers pharmacies prescription drug plan sponsors authorizes secretary instead like federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs requires savings use authority provided act strengthen program reduce federal deficit requires secretary ensure eligible individual choice enrollment comprehensive prescription drug plan area individual resides case plan available opportunity enroll comprehensive fallback prescription drug plan |
110-S-273 | Prescription Drug and Health Improvement Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to prescription drug plans to repeal the prohibition against interference by the Secretary of Health and Human Services with negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, and against the Secretary's requiring a particular formulary or instituting a price structure for the reimbursement of covered part D (Voluntary Prescription Drug Benefit Program) drugs. Grants the Secretary authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs. | Health | Drug Coverage and Cost | Health | 2007-01-11 | prescription drug health improvement act amends title xviii medicare social security act ssa respect prescription drug plans repeal prohibition interference secretary health_and_human_services negotiations drug manufacturers pharmacies prescription drug plan sponsors secretary requiring particular formulary instituting price structure reimbursement covered voluntary prescription drug benefit program drugs grants secretary authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs |
110-S-1589 | Drug Rebate Equalization Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to reduce the costs of prescription drugs for enrollees of Medicaid managed care organizations by extending to such organizations the discounts offered under fee-for-service Medicaid plans. Requires the state contract with a Medicaid managed care organization to provide that: (1) payment for covered outpatient drugs dispensed to Medicaid-eligible individuals enrolled with the organization shall be subject to the same rebate as the state is subject to; and (2) the state shall allow the organization to collect such rebates from manufacturers. Requires also that capitation rates paid to the organization be: (1) based on actual cost experience related to rebates; and (2) subject to the federal regulations requiring actuarially sound rates. | Health | Drug Coverage and Cost | Health | 2007-06-11 | drug rebate equalization act amends title xix medicaid social security act reduce costs prescription drugs enrollees medicaid managed care organizations extending organizations discounts offered fee service medicaid plans requires state contract medicaid managed care organization provide payment covered outpatient drugs dispensed medicaid eligible individuals enrolled organization shall subject rebate state subject state shall allow organization collect rebates manufacturers requires capitation rates paid organization based actual cost experience related rebates subject federal regulations requiring actuarially sound rates |
110-S-1827 | Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require prompt payment of clean claims to pharmacies by prescription drug plans and Medicare Advantage prescription drug plans. Defines prompt payment as within 14 days from submission for claims submitted electronically, and within 30 days for claims submitted otherwise. Requires payment of interest, also, if a payment is not issued, mailed, or otherwise transmitted within the applicable number of calendar days. Prohibits a Medicare prescription drug card issued by a prescription drug plan sponsor from displaying the name, brand, or trademark (co-branding) of any pharmacy. Revises requirements for a covered medication therapy management program, allowing it to be furnished by a health care provider, other than a pharmacist, with advanced training in medication management. Requires the Secretary of Health and Human Services to specify: (1) the population of part D eligible individuals appropriate for services under a medication therapy management program, based on certain characteristics; and (2) a minimum defined package of medication therapy management services that shall be provided to each enrollee.Revises requirements for pharmacy fees.Directs the Secretary to establish: (1) a two-year demonstration program to examine the impact of medication therapy management furnished by a pharmacist in a community-based or ambulatory-based setting on quality of care, spending, and patient health; and (2) a Best Practices Commission to develop a best practices model for medication therapy management. | Health | Drug Coverage and Cost | Health | 2007-07-19 | recognition medicare act amends voluntary prescription drug benefit program title xviii medicare social security act require prompt payment clean claims pharmacies prescription drug plans medicare_advantage prescription drug plans defines prompt payment days submission claims submitted electronically days claims submitted requires payment interest payment issued mailed transmitted applicable number calendar days prohibits medicare prescription drug card issued prescription drug plan sponsor displaying brand trademark branding pharmacy revises requirements covered medication therapy management program allowing furnished health care provider pharmacist advanced training medication management requires secretary health_and_human_services specify population eligible individuals appropriate services medication therapy management program based certain characteristics minimum defined package medication therapy management services shall provided enrollee revises requirements pharmacy fees directs secretary establish year demonstration program examine impact medication therapy management furnished pharmacist community based ambulatory based setting quality care spending patient health develop best practices model medication therapy management |
110-S-1887 | Medicare Access to Critical Medications Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require prescription drug plan (PDP) formularies to include all or substantially all covered part D drugs in the therapeutic classes: (1) anticonvulsants; (2) antineoplastics; (3) antiretrovirals; (4) antidepressants; (5) antipsychotics; and (6) immunosuppressants.Prohibits the application of a utilization management tool, such as prior authorization or step therapy, to such drugs in certain cases.Prescribes requirements for treatment of such drugs when a determination or reconsideration is requested, as well as the treatment of appeals for such drugs.Establishes data reporting requirements for such drug categories and classes. | Health | Drug Coverage and Cost | Health | 2007-07-26 | medicare access critical medications act amends voluntary prescription drug benefit program title xviii medicare social security act require prescription drug plan pdp formularies include substantially covered drugs therapeutic classes antidepressants prohibits application utilization management tool prior authorization step therapy drugs certain cases prescribes requirements treatment drugs determination reconsideration requested treatment appeals drugs establishes data reporting requirements drug categories classes |
110-S-1951 | Fair Medicaid Drug Payment Act of 2007 - Amends title XIX (Medicaid) of the Social Security Act to direct the Secretary of Health and Human Services to calculate the federal upper reimbursement limit as no less than 300% of the weighted average (based on utilization) of the most recent average manufacturer prices (AMPs) for pharmaceutically and therapeutically equivalent multiple source drug products available for purchase by retail community pharmacies on a nationwide basis. Directs the Secretary to implement a smoothing process for AMPs to ensure that federal upper reimbursement limits do not vary significantly from month to month as a result of rebates, discounts, and other pricing practices. Requires a state plan to subject to prior authorization all covered outpatient drug products that are innovator multiple source drugs, if such drug products are more expensive than other biologically and therapeutically equivalent drug products available for purchase in that state by retail community pharmacies. Revises requirements for monthly reports to the Secretary of price information by manufacturers subject to rebate agreements. | Health | Drug Coverage and Cost | Health | 2007-08-02 | fair medicaid drug payment act amends title xix medicaid social security act direct secretary health_and_human_services calculate federal upper reimbursement limit weighted average based utilization recent average manufacturer prices amps therapeutically equivalent multiple source drug products available purchase retail community pharmacies nationwide basis directs secretary implement process amps ensure federal upper reimbursement limits vary significantly month month result rebates discounts pricing practices requires state plan subject prior authorization covered outpatient drug products innovator multiple source drugs drug products expensive biologically therapeutically equivalent drug products available purchase state retail community pharmacies revises requirements monthly reports secretary price information manufacturers subject rebate agreements |
110-S-1954 | Pharmacy Access Improvement (PhAIm) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program ) of title XVIII (Medicare) of the Social Security Act (SSA) with respect to participating pharmacies and standards for access to them. Requires that such standards ensure that enrollees residing in long-term care facilities have access to a long-term care network pharmacy.Requires prompt payment of clean claims to pharmacies by prescription drug plans (PDPs) and Medicare Advantage prescription drug plans (MA-PD Plans). Defines prompt payment as payment occurring within 14 days from submission for claims submitted electronically, and within 30 days for claims submitted otherwise. Requires payment of interest if a payment is not issued, mailed, or otherwise transmitted within the applicable number of calendar days.Directs the Secretary of Health and Human Services to establish a 24-hour toll-free telephone number dedicated to providing Medicare prescription drug benefit information to pharmacists and pharmacy staff.Requires PDP sponsors to establish toll-free pharmacy and physician and provider hotlines.Prohibits a Medicare prescription drug card issued by a PDP sponsor from displaying the name, brand, logo, or trademark (co-branding) of any pharmacy.Provides for submission of claims by pharmacies located in or contracting with long-term care facilities.Requires the Inspector General of the Department of Health and Human Services to analyze and report to the Secretary on the cost of dispensing covered part D drugs under a PDP or an MA-PD plan.Provides that, if the PDP sponsor uses a standard for reimbursement of pharmacies based on the cost of a drug, each contract entered into with such sponsor with respect to the plan shall require the sponsor to update the standard at least once every seven days. | Health | Drug Coverage and Cost | Health | 2007-08-02 | pharmacy access improvement act amends voluntary prescription drug benefit program title xviii medicare social security act ssa respect participating pharmacies standards access requires standards ensure enrollees residing long term care facilities access long term care network pharmacy requires prompt payment clean claims pharmacies prescription drug plans pdps medicare_advantage prescription drug plans ma-pd plans defines prompt payment payment occurring days submission claims submitted electronically days claims submitted requires payment interest payment issued mailed transmitted applicable number calendar days directs secretary health_and_human_services establish hour toll free telephone number dedicated providing medicare prescription drug benefit information pharmacists pharmacy staff requires pdp sponsors establish toll free pharmacy physician provider hotlines prohibits medicare prescription drug card issued pdp sponsor displaying brand logo trademark branding pharmacy provides submission claims pharmacies located contracting long term care facilities requires inspector general department_of_health_and_human_services analyze report secretary cost dispensing covered drugs pdp ma-pd plan provides pdp sponsor uses standard reimbursement pharmacies based cost drug contract entered sponsor respect plan shall require sponsor update standard seven days |
110-S-2013 | Amends title XIX (Medicaid) of the Social Security Act, as amended by the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007, to: (1) apply the required use of tamper-resistant prescription pads under the Medicaid Program at first only to Controlled Substances Act schedule II narcotic drugs prescribed after September 30, 2007; and (2) delay the application of the requirement to other covered outpatient prescription drugs until after March 31, 2009. | Health | Drug Coverage and Cost | Health | 2007-08-03 | amends title xix medicaid social security act amended katrina_recovery iraq_accountability_appropriations_act apply required use tamper resistant prescription pads medicaid program controlled substances act schedule narcotic drugs prescribed september delay application requirement covered outpatient prescription drugs march |
110-S-2085 | Patient and Pharmacy Protection Act of 2007 - Amends the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007 to delay for six months, from September 30, 2007, through March 31, 2008, the effective date of the requirement to use tamper-resistant prescription pads under title XIX (Medicaid) of the Social Security Act to prescribe covered outpatient drugs. | Health | Drug Coverage and Cost | Health | 2007-09-21 | patient pharmacy protection act amends katrina_recovery iraq_accountability_appropriations_act delay months september march effective date requirement use tamper resistant prescription pads title xix medicaid social security act prescribe covered outpatient drugs |
110-S-2089 | Medicare Prescription Drug Gap Reduction Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices.Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs.States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan.Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D. | Health | Drug Coverage and Cost | Health | 2007-09-25 | amends title xviii medicare social security act ssa reduce coverage gap prescription drug coverage ssa voluntary prescription drug benefit program based savings medicare program resulting negotiation prescription drug prices grants secretary health_and_human_services authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs states secretary shall required negotiate contracts manufacturers covered drugs fallback prescription drug plan participate negotiation contracts covered drug request approved prescription drug plan prohibits secretary requiring particular formulary instituting price structure reimbursement covered drugs order carry promote competition |
110-S-2190 | Medicare Mental Health Prescription Drug Access Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to cover barbiturates and benzodiazepines as Medicare part D drugs, beginning in 2008. | Health | Drug Coverage and Cost | Health | 2007-10-17 | amends title xviii medicare social security act cover benzodiazepines medicare drugs beginning |
110-S-2219 | Medicare Prescription Drug Savings and Choice Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan; and (3) pharmacy payments under such a plan. | Health | Drug Coverage and Cost | Health | 2007-10-23 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan pharmacy payments plan |
110-S-2320 | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B. Makes him or her responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients. | Health | Drug Coverage and Cost | Health | 2007-11-07 | comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients |
110-S-2408 | Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to require the Secretary of Health and Human Services to: (1) make incentive payments for physician use of an electronic prescription drug program (E-prescribing); and (2) reduce by 10% the fee schedule amount for failure to use E-prescribing. Directs the Administrator of the Centers for Medicare & Medicaid Services to report to Congress on progress on implementing E-prescribing under the Medicare electronic prescription drug program. | Health | Drug Coverage and Cost | Health | 2007-12-05 | meds act amends title xviii medicare social security act require secretary health_and_human_services incentive payments physician use electronic prescription drug program prescribing reduce fee schedule failure use prescribing directs administrator centers report congress progress implementing prescribing medicare electronic prescription drug program |
110-S-2414 | Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2008, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula. | Health | Drug Coverage and Cost | Health | 2007-12-05 | reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula |
110-S-3068 | Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 [sic] - Amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to prohibit a group health plan, and a health insurance issuer providing group coverage, from: (1) excluding or restricting benefits for prescription contraceptive drugs, devices, and outpatient services if the plan provides benefits for other outpatient prescription drugs, devices, or outpatient services; (2) denying eligibility based on use or potential use of such items or services; (3) providing monetary payments or rebates to a covered individual to encourage acceptance of less than the minimum protections available; (4) penalizing, reducing, or limiting a professional's reimbursement because the professional prescribed such drugs or devices or provided such services; or (5) providing incentives to a professional to induce the professional to withhold such drugs, devices, or services. Applies such prohibitions to coverage offered in the individual market. | Health | Drug Coverage and Cost | Health | 2008-05-22 | equity prescription insurance contraceptive coverage act sic amends employee retirement income security act erisa public_health_service_act prohibit group health plan health insurance issuer providing group coverage excluding restricting benefits prescription contraceptive drugs devices outpatient services plan provides benefits outpatient prescription drugs devices outpatient services denying eligibility based use potential use items services providing monetary payments rebates covered individual encourage acceptance minimum protections available penalizing reducing limiting professional reimbursement professional prescribed drugs devices provided services providing incentives professional induce professional withhold drugs devices services applies prohibitions coverage offered individual market |
111-HR-684 | Medicare Prescription Drug Savings and Choice Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; and (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan. | Health | Drug Coverage and Cost | Health | 2009-01-26 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan |
111-HR-1392 | Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers. | Health | Drug Coverage and Cost | Health | 2009-03-09 | amends title xviii medicare social security act respect use average sales price methodology calculating payments drugs biologicals medicare supplementary_medical_insurance excludes manufacturer average sales price calculating payments customary prompt pay discounts extended wholesalers |
111-HR-1421 | Nino's Act - Amends title XIX (Medicaid) of the Social Security Act to provide for mandatory Medicaid coverage of drugs prescribed for certain research study child participants, regardless of Medicaid eligibility otherwise, if the state provides drug coverage. | Health | Drug Coverage and Cost | Health | 2009-03-10 | act amends title xix medicaid social security act provide mandatory medicaid coverage drugs prescribed certain research study child participants regardless medicaid eligibility state provides drug coverage |
111-HR-1458 | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B and makes the individual responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients. | Health | Drug Coverage and Cost | Health | 2009-03-12 | comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare makes individual responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients |
111-HR-2860 | Medicare Drug Savings Through Choice Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to: (1) offer a Medicare operated prescription drug plan with a service area that consists of the entire United States; (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered Medicare part D drugs; and (3) encourage the use of more affordable therapeutic equivalents. Requires the monthly beneficiary premium charged under such a plan to be uniform nationally. Requires adjustment of such premium amount in case of supplemental prescription drug coverage. | Health | Drug Coverage and Cost | Health | 2009-06-12 | amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services offer medicare operated prescription drug plan service area consists entire united_states negotiate pharmaceutical manufacturers reduce purchase cost covered medicare drugs encourage use affordable therapeutic equivalents requires monthly beneficiary premium charged plan uniform nationally requires adjustment premium case supplemental prescription drug coverage |
111-HR-3089 | Accountability and Transparency in Medicare Marketing Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to request the National Association of Insurance Commissioners (NAIC) to develop standardized marketing requirements for: (1) Medicare Advantage organizations with respect to Medicare Advantage plans; and (2) prescription drug plan (PDP) sponsors with respect to Medicare PDPs. Requires such requirements to include prohibitions on certain activities and certain limitations. Requires state certification before HHS waiver of licensing requirements under the Medicare PDP. Directs the Secretary to request NAIC to establish a committee to study and make recommendations to the Secretary and Congress on the establishment of standardized benefit packages for Medicare Advantage plans and for Medicare PDPs and their regulation. | Health | Drug Coverage and Cost | Health | 2009-06-26 | accountability transparency medicare marketing act amends title xviii medicare social security act direct secretary health_and_human_services hhs request national_association_of_insurance_commissioners naic develop standardized marketing requirements medicare advantage organizations respect medicare_advantage plans prescription drug plan pdp sponsors respect medicare pdps requires requirements include prohibitions certain activities certain limitations requires state certification hhs waiver licensing requirements medicare pdp directs secretary request naic establish committee study recommendations secretary congress establishment standardized benefit packages medicare_advantage plans medicare pdps regulation |
111-HR-3108 | Medication Therapy Management Benefits Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require that the medication therapy management (MTM) services prescription drug plan (PDP) sponsors offer to targeted beneficiaries include: (1) an annual comprehensive medication review furnished person-to-person by a licensed pharmacist; (2) at least quarterly targeted medication reviews, also furnished person-to-person by a licensed pharmacist; and (3) followup interventions, person-to-person or through other interactive means, on a schedule and frequency recommended by the prescriber or a licensed pharmacist. Increases the number of diseases and conditions for which beneficiaries may be targeted for MTM services. Requires a PDP sponsor to identify a process, subject to approval by the Secretary of Health and Human Services (HHS), that allows pharmacists or other qualified providers to identify enrollees for MTM interventions where such individuals are not targeted beneficiaries or are not otherwise offered MTM services. Requires any MTM program to offer both comprehensive and targeted medication reviews to individuals dually eligible for both Medicare and Medicaid (under SSA title XIX), regardless of whether they are MTM-targeted beneficiaries. Requires a PDP sponsor to offer any willing pharmacy in its network the ability to provide MTM services. Requires the PDP sponsor to reimburse pharmacists and other entities furnishing MTM services based on the resources used and the time required to provide such services. Directs the Secretary to: (1) establish measures and standards for data collection by PDP sponsors to evaluate performance of pharmacies and other entities in furnishing MTM services; and (2) support the continued development and refinement of performance measures. Provides pharmacies and other entities that furnish MTM services with additional incentive payments based on their performance in meeting quality measures established under this Act. | Health | Drug Coverage and Cost | Health | 2009-06-26 | medication therapy management benefits act amends voluntary prescription drug benefit program title xviii medicare social security act ssa require medication therapy management services prescription drug plan pdp sponsors offer targeted beneficiaries include annual comprehensive medication review furnished person person licensed pharmacist quarterly targeted medication reviews furnished person person licensed pharmacist interventions person person interactive means schedule frequency recommended prescriber licensed pharmacist increases number diseases conditions beneficiaries targeted services requires pdp sponsor identify process subject approval secretary health_and_human_services hhs allows pharmacists qualified providers identify enrollees interventions individuals targeted beneficiaries offered services requires program offer comprehensive targeted medication reviews individuals dually eligible medicare medicaid ssa title xix regardless targeted beneficiaries requires pdp sponsor offer willing pharmacy network ability provide services requires pdp sponsor reimburse pharmacists entities furnishing services based resources time required provide services directs secretary establish measures standards data collection pdp sponsors evaluate performance pharmacies entities furnishing services support continued development refinement performance measures provides pharmacies entities furnish services additional incentive payments based performance meeting quality measures established act |
111-HR-3152 | Helping Seniors Choose their Medicare Drug Plan - Amends Part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act with respect to the process for enrolling a full-benefit dual eligible individual (eligible for both Medicare and Medicaid benefits), who has otherwise failed to enroll in a prescription drug plan (PDP) or in an MedicareAdvantage-Prescription Drug (MA-PD) plan, in a PDP with a beneficiary premium that does not exceed a full premium subsidy. Repeals the requirement that the Secretary of Health and Human Services (HHS) enroll such an individual on a random basis among all plans in the PDP region. Requires the Secretary to enroll the individual in the most appropriate plan based on guidelines, established by the Secretary, that account for the individual's previous prescription drug utilization. | Health | Drug Coverage and Cost | Health | 2009-07-09 | helping seniors choose medicare drug plan amends voluntary prescription drug benefit program title xviii medicare social security act respect process enrolling benefit dual eligible individual eligible medicare medicaid benefits failed enroll prescription drug plan pdp ma-pd plan pdp beneficiary premium exceed premium subsidy repeals requirement secretary health_and_human_services hhs enroll individual random basis plans pdp region requires secretary enroll individual appropriate plan based guidelines established secretary account individual previous prescription drug utilization |
111-HR-3483 | Steps Toward Access and Reform Act of 2009 or the STAR Act of 2009 - Sets conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce. Sets a statute of limitations of three years after the date of manifestation of injury or one year after the claimant discovers the injury, with certain exceptions. Provides that nothing in this Act limits recovery of the full amount of available economic damages. Limits noneconomic damages to $250,000. Makes each party liable only for the amount of damages directly proportional to such party's percentage of responsibility. Allows the court to restrict the payment of attorney contingency fees. Limits the fees to a decreasing percentage based on the increasing value of the amount awarded. Allows the introduction of collateral source benefits and the amount paid to secure such benefits as evidence. Prohibits a provider of such benefits from recovering any amount from an award in a health care lawsuit involving injury or wrongful death. Authorizes the award of punitive damages only where: (1) it is proven by clear and convincing evidence that a person acted with malicious intent to injure the claimant or deliberately failed to avoid unnecessary injury the claimant was substantially certain to suffer; and (2) compensatory damages are awarded. Limits punitive damages to the greater of two times the amount of economic damages or $250,000. Denies punitive damages in the case of products approved, cleared, or licensed by the Food and Drug Administration (FDA) or otherwise considered in compliance with FDA standards. Provides for periodic payments of future damages. Directs the Secretary of Health and Human Services (HHS) to carry out a program of loan forgiveness for primary health care providers who agree to provide medical services in medically underserved communities for a period of not less than four years. Amends the Internal Revenue Code to allow: (1) providers of medical care a bad debt tax deduction for up to 75% of their cost in providing uncompensated medical care to low-income individuals; and (2) a refund of excise tax on fuel used in mobile mammography vehicles; and (3) a tax deduction for the travel expenses of veterans and a family member to a medical center of the Department of Veterans Affairs. Amends the Bipartisan Trade Promotion Authority Act of 2002 to include among the overall trade negotiating objectives of the United States avoiding negotiating trade agreements that could restrict, or be interpreted to restrict, the access of consumers in the United States to certain pharmaceutical imports. Amends title XVIII (Medicare) of the Social Security Act to authorize payment after January 1, 2010, for chest radiology services that use computer-aided detection technology for the early detection of lung cancer. | Health | Drug Coverage and Cost | Health | 2009-07-31 | steps access reform act star act sets conditions lawsuits arising health care liability claims health care goods services medical product affecting interstate commerce sets statute limitations years date manifestation injury year claimant discovers injury certain exceptions provides act limits recovery available economic damages limits noneconomic damages makes party liable damages directly proportional party percentage responsibility allows court restrict payment attorney contingency fees limits fees decreasing percentage based increasing value awarded allows introduction collateral source benefits paid secure benefits evidence prohibits provider benefits recovering award health care lawsuit involving injury wrongful death authorizes award punitive damages proven clear convincing evidence person acted malicious intent injure claimant deliberately failed avoid unnecessary injury claimant substantially certain suffer compensatory damages awarded limits punitive damages greater times economic damages denies punitive damages case products approved cleared licensed food_and_drug_administration fda considered compliance fda standards provides periodic payments future damages directs secretary health_and_human_services hhs carry program loan forgiveness primary health care providers agree provide medical services medically underserved communities period years amends internal revenue code allow providers medical care bad debt tax deduction cost providing uncompensated medical care low income individuals refund excise tax fuel mobile mammography vehicles tax deduction travel expenses veterans family member medical center department_of_veterans_affairs amends include overall trade negotiating objectives united_states avoiding negotiating trade agreements restrict interpreted restrict access consumers united_states certain pharmaceutical imports amends title xviii medicare social security act authorize payment january chest services use computer aided detection technology early detection lung cancer |
111-HR-4199 | Patient Health and Real Medication Access Cost Savings Act of 2009 or the PHARMACY Bill - Declares that a consumer shall have the right to choose to purchase prescription drugs from any domestic pharmacy that meets all applicable federal and state license and permit requirements. Directs the Secretary of Health and Human Services (HHS) to issue regulations that: (1) prohibit a pharmacy benefit manager (PBM) from providing incentives to, encouraging, or requiring pharmacy benefit plan enrollees to use certain pharmacies or from excluding an eligible pharmacy from a plan's pharmacy network; (2) require a PBM to ensure that pharmacy benefit plan enrollees pay a specified copayment for brand name drugs; (3) require a PBM to reimburse a pharmacy in the network of a pharmacy benefit plan that is federally funded, at specified rates, for brand-name drugs, generic drugs, and additional professional services; (4) require a PBM to be reimbursed by a pharmacy benefit plan sponsor for adjudicating and processing claims; (5) limit the amount that a PBM charges a pharmacy benefit plan sponsor for a drug that is dispensed to enrollees to the amount the PBM paid the pharmacy for such drug; (6) require a manufacturer of prescription drugs to pay all rebates directly to the pharmacy benefit plan sponsor and not to a PBM; and (7) require a pharmacy benefit plan sponsor to provide a list of the wholesale acquisition costs of the top 500 most frequently prescribed drugs to physicians in a plan any insurance-related charge of which is underwritten by a federal, state, or local government. Amends title XVIII (Medicare) of the Social Security Act to include pharmacist services as "medical and other health services" under Medicare. Directs the Secretary, by January 1, 2011, to establish a pharmaceutical access program to provide affordable prescription drugs to individuals who receive drug benefits under federal programs (except Medicaid). Requires: (1) a pharmacy that dispenses prescription drugs in the United States to remit to the Secretary 50 cents for each brand name prescription and $1.00 for generic drug prescription dispensed; and (2) the sponsor of a pharmacy benefit plan that is not federally funded to increase the professional dispensing fee paid to pharmacies by the same amounts. Requires the use of funds generated from such fees to provide affordable access to prescription drugs to low-income individuals who have enrolled in the program. | Health | Drug Coverage and Cost | Health | 2009-12-03 | patient health real medication access cost savings act pharmacy bill declares consumer shall right choose purchase prescription drugs domestic pharmacy meets applicable federal state license permit requirements directs secretary health_and_human_services hhs issue regulations prohibit pharmacy benefit manager pbm providing incentives encouraging requiring pharmacy benefit plan enrollees use certain pharmacies excluding eligible pharmacy plan pharmacy network require pbm ensure pharmacy benefit plan enrollees pay specified copayment brand drugs require pbm reimburse pharmacy network pharmacy benefit plan federally funded specified rates brand drugs generic drugs additional professional services require pbm reimbursed pharmacy benefit plan sponsor adjudicating processing claims limit pbm charges pharmacy benefit plan sponsor drug dispensed enrollees pbm paid pharmacy drug require manufacturer prescription drugs pay rebates directly pharmacy benefit plan sponsor pbm require pharmacy benefit plan sponsor provide list wholesale acquisition costs frequently prescribed drugs physicians plan insurance related charge underwritten federal state local government amends title xviii medicare social security act include pharmacist services medical health services medicare directs secretary january establish pharmaceutical access program provide affordable prescription drugs individuals receive drug benefits federal programs medicaid requires pharmacy dispenses prescription drugs united_states remit secretary cents brand prescription generic drug prescription dispensed sponsor pharmacy benefit plan federally funded increase professional dispensing fee paid pharmacies amounts requires use funds generated fees provide affordable access prescription drugs low income individuals enrolled program |
111-HR-4752 | Medicare Prescription Drug Price Negotiation Act of 2010 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2010-03-03 | medicare prescription drug price negotiation act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services hhs negotiate pharmaceutical manufacturers prices charged medicare prescription drug plan pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan |
111-HR-5732 | Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature. | Health | Drug Coverage and Cost | Health | 2010-07-14 | label prescription parity act amends voluntary prescription drug benefit program title xviii medicare social security act permit prescription drug plan pdp sponsor offering pdp medicareadvantage organization offering ma-pd plan offer coverage covered drugs uses determined medically accepted indications based guidance provided secretary health_and_human_services hhs determining accepted uses covered drugs supportive clinical evidence peer reviewed medical literature |
111-S-11 | Amends the Public Health Service Act to consider certain drugs designated for a rare disease or condition as covered outpatient drugs for children's hospitals under the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees). | Health | Drug Coverage and Cost | Health | 2010-09-28 | amends public_health_service_act consider certain drugs designated rare disease condition covered outpatient drugs children hospitals 340b drug discount program program limiting cost covered outpatient drugs certain federal grantees |
111-S-266 | Medicare Prescription Drug Gap Reduction Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices. Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs. States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan. Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D. | Health | Drug Coverage and Cost | Health | 2009-01-15 | amends title xviii medicare social security act ssa reduce coverage gap prescription drug coverage ssa voluntary prescription drug benefit program based savings medicare program resulting negotiation prescription drug prices grants secretary health_and_human_services authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs states secretary shall required negotiate contracts manufacturers covered drugs fallback prescription drug plan participate negotiation contracts covered drug request approved prescription drug plan prohibits secretary requiring particular formulary instituting price structure reimbursement covered drugs order carry promote competition |
111-S-330 | Medicare Prescription Drug Savings and Choice Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; and (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan. | Health | Drug Coverage and Cost | Health | 2009-01-27 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan |
111-S-511 | Access to Durable Medical Equipment Act - Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act, as amended by the Medicare Improvements for Patients and Providers Act of 2008, with respect to Medicare quality standards for suppliers of items and services which shall be applied by recognized independent accreditation organizations. Applies to pharmacies and pharmacists the eligible professional exemption from such accreditation requirements, unless such standards are designed specifically for application to pharmacies and pharmacists. Authorizes the Secretary of Health and Human Services to exempt pharmacies and pharmacists from such standards if licensing, accreditation, or other mandatory quality requirements apply to them with respect to the furnishing of items and services. | Health | Drug Coverage and Cost | Health | 2009-03-03 | access durable medical equipment act amends supplementary_medical_insurance title xviii medicare social security act amended medicare_improvements_for_patients_and_providers_act respect medicare quality standards suppliers items services shall applied recognized independent accreditation organizations applies pharmacies pharmacists eligible professional exemption accreditation requirements standards designed specifically application pharmacies pharmacists authorizes secretary health_and_human_services exempt pharmacies pharmacists standards licensing accreditation mandatory quality requirements apply respect furnishing items services |
111-S-565 | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving additional coverage for immunosuppressive drugs. Deems such individual to be enrolled under Medicare part B and makes the individual responsible for the full amount of the applicable premiums. Applies deductible and coinsurance requirements to the provision of such drugs. Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to set forth requirements for group health plans to provide coverage of immunosuppressive drugs for kidney transplant patients. | Health | Drug Coverage and Cost | Health | 2009-03-10 | comprehensive immunosuppressive drug coverage kidney transplant patients act amends ssa title survivors disability insurance oasdi continue entitlement prescription drugs immunosuppressive therapy furnished individual receives kidney transplant payment medicare extend medicare secondary payer requirements end stage renal disease esrd beneficiaries amends title xviii medicare ssa apply special rules kidney transplant recipients receiving additional coverage immunosuppressive drugs deems individual enrolled medicare makes individual responsible applicable premiums applies deductible coinsurance requirements provision drugs amends public_health_service_act employee retirement income security act erisa internal revenue code set forth requirements group health plans provide coverage immunosuppressive drugs kidney transplant patients |
111-S-677 | Reforming an Entitlement through Premium Adjustments based on Income Resources (REPAIR) Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require an income-related reduction in the part D premium subsidy. Declares that, in the case of an individual whose modified adjusted gross income exceeds a certain applicable threshold amount for a month after December 2009, the monthly amount of the part D premium subsidy shall be reduced (and the monthly beneficiary premium shall be increased) by the monthly adjustment amount determined according to a specified formula. | Health | Drug Coverage and Cost | Health | 2009-03-24 | reforming entitlement based act amends voluntary prescription drug benefit program title xviii medicare social security act require income related reduction premium subsidy declares case individual modified adjusted gross income exceeds certain applicable threshold month december monthly premium subsidy shall reduced monthly beneficiary premium shall increased monthly adjustment determined according specified formula |
111-S-1221 | Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance). Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers. | Health | Drug Coverage and Cost | Health | 2009-06-09 | amends title xviii medicare social security act respect use average sales price methodology calculating payments drugs biologicals medicare supplementary_medical_insurance excludes manufacturer average sales price calculating payments customary prompt pay discounts extended wholesalers |
111-S-1239 | 340B Program Improvement and Integrity Act of 2009 - Amends the Public Health Service Act to expand the drug discount program to allow participation as a covered entity by certain: (1) children's hospitals; (2) critical access hospitals; and (3) rural referral centers. Expands the program to include drugs used in connection with an inpatient or outpatient service by enrolled hospitals (currently, only outpatient drugs are covered under the program). Prohibits enrolled hospitals from obtaining covered outpatient drugs through a group purchasing arrangement. Requires the Secretary of Health and Human Services (HHS) to establish reasonable exceptions to such prohibition, including for drugs unavailable through the program and to facilitate generic substitution when a generic covered drug is available at a lower price. Requires a hospital enrolled in the 340B drug discount program to issue a credit to a state Medicaid program for inpatient drugs provided to Medicaid recipients. Requires the Secretary to: (1) provide for improvements in compliance by manufacturers and covered entities with the requirements of the drug discount program; and (2) establish and implement an administrative process for resolving claims by covered entities and manufacturers of violations of such requirements. Requires manufacturers to offer each covered entity covered drugs for purchase at or below the applicable ceiling price if such a drug is made available to any other purchaser at any price. | Health | Drug Coverage and Cost | Health | 2009-06-11 | integrity act amends public_health_service_act expand drug discount program allow participation covered entity certain children hospitals critical access hospitals rural referral centers expands program include drugs connection inpatient outpatient service enrolled hospitals currently outpatient drugs covered program prohibits enrolled hospitals obtaining covered outpatient drugs group purchasing arrangement requires secretary health_and_human_services hhs establish reasonable exceptions prohibition including drugs unavailable program facilitate generic substitution generic covered drug available lower price requires hospital enrolled 340b drug discount program issue credit state medicaid program inpatient drugs provided medicaid recipients requires secretary provide improvements compliance manufacturers covered entities requirements drug discount program establish implement administrative process resolving claims covered entities manufacturers violations requirements requires manufacturers offer covered entity covered drugs purchase applicable ceiling price drug available purchaser price |
111-S-1312 | Medicare Safe Needle Disposal Coverage Act of 2009 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to cover as a part D drug any devices approved for home use by the Food and Drug Administration (FDA) for the safe and effective containment, removal, decontamination, and disposal of home-generated needles, syringes, and other sharps through a sharps container, decontamination/destructive device, or sharps-by-mail program or similar program. | Health | Drug Coverage and Cost | Health | 2009-06-19 | medicare_safe_needle_disposal_coverage_act amends voluntary prescription drug benefit program title xviii medicare social security act cover drug devices approved home use food_and_drug_administration fda safe effective containment removal decontamination disposal home generated needles syringes sharps sharps container decontamination destructive device sharps mail program similar program |
111-S-3401 | Addressing Cost Containment Measures To Ensure the Sustainability and Success of ADAP Act or the ACCESS ADAP Act - Transfers funds from discretionary amounts appropriated under the American Recovery and Reinvestment Act that remain unobligated to the Secretary of Health and Human Services (HHS) to be used in FY2010 to provide assistance in reducing AIDS Drug Assistance Program waiting lists and to address other cost containment measures that state AIDS Drug Assistance Programs implement after January 1, 2009. Requires amounts transferred under this Act to be used by states in a manner consistent with their state programs. Requires the Secretary, in allocating such funds, to: (1) give special consideration to the total scope and the basis of a state's needs, including the total number of patients on a waiting list, eligibility requirements, and other cost containment measures; and (2) ensure that funds be used only to provide treatments to individuals who were eligible to participate in the state program on the date of enactment of this Act. | Health | Drug Coverage and Cost | Health | 2010-05-24 | addressing cost containment measures ensure sustainability success act access act transfers funds discretionary amounts appropriated american_recovery_and_reinvestment_act remain unobligated secretary health_and_human_services hhs fy2010 provide assistance reducing aids drug assistance program waiting lists address cost containment measures state aids drug assistance programs implement january requires amounts transferred act states manner consistent state programs requires secretary allocating funds special consideration total scope basis state needs including total number patients waiting list eligibility requirements cost containment measures ensure funds provide treatments individuals eligible participate state program date enactment act |
111-S-3413 | Medicare Prescription Drug Price Negotiation Act of 2010 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2010-05-25 | medicare prescription drug price negotiation act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services hhs negotiate pharmaceutical manufacturers prices charged medicare prescription drug plan pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan |
111-S-4006 | Addressing Cost Containment Measures To Ensure the Sustainability and Success of ADAP Act or the ACCESS ADAP Act - Requires specified funds to be transferred to the Secretary of Health and Human Services (HHS) from discretionary amounts appropriated under the American Recovery and Reinvestment Act that remain unobligated, to be obligated during the FY2010 grant period under the AIDS Drug Assistance Program to provide assistance in reducing waiting lists and to address other cost containment measures that state AIDS Drug Assistance Programs implement after January 1, 2009. Requires amounts transferred under this Act to be used by states in a manner consistent with their state programs. Requires the Secretary, in allocating such funds, to: (1) give special consideration to the total scope and the basis of a state's needs, including the total number of patients on a waiting list, eligibility requirements, and other cost containment measures; and (2) ensure that funds be used only to provide treatments to individuals who were eligible to participate in the state program on the date of enactment of this Act or who would have been eligible to participate in the state program but were not so eligible because of the implementation of cost-containment measures after January 1, 2009. | Health | Drug Coverage and Cost | Health | 2010-12-03 | addressing cost containment measures ensure sustainability success act access act requires specified funds transferred secretary health_and_human_services hhs discretionary amounts appropriated american_recovery_and_reinvestment_act remain unobligated obligated fy2010 grant period aids drug assistance program provide assistance reducing waiting lists address cost containment measures state aids drug assistance programs implement january requires amounts transferred act states manner consistent state programs requires secretary allocating funds special consideration total scope basis state needs including total number patients waiting list eligibility requirements cost containment measures ensure funds provide treatments individuals eligible participate state program date enactment act eligible participate state program eligible implementation cost containment measures january |
111-S-4024 | Medicare Enhancements for Needed Drugs Act of 2010 - Directs the Comptroller General to review and report to Congress on the retail cost of prescription drugs in the United States during 2004 through 2010, with an emphasis on the prescription drugs most utilized for individuals age 65 or older. Requires the Comptroller General to conduct an ongoing study that compares the average retail cost in the United States for each of the 20 most utilized prescription drugs for individuals age 65 or older with: (1) the average prices at which private health plans, the Department of Defense (DOD) under the Defense Health Program, and the Department of Veterans Affairs (VA) acquire each such drug; and (2) the average negotiated price for each such drug that eligible beneficiaries have access to under a Medicare prescription drug plan providing only basic prescription drug coverage. Amends title XVIII (Medicare) of the Social Security Act (SSA) to include in the comparative plan information for beneficiaries under Medicare part D (Voluntary Prescription Drug Benefit Program) a comparison of average aggregate prescription drug plan beneficiary costs and savings with such costs for a beneficiary with no prescription drug plan. Repeals the prohibition against interference by the Secretary of Health and Human Services (HHS) with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors. Authorizes the Secretary instead, like other federal entities that purchase prescription drugs in bulk, to negotiate contracts with manufacturers of covered part D drugs. Requires the use of the resulting savings to the Medicare Prescription Drug Account to strengthen the part D program and to reduce the federal deficit. Requires the Secretary to ensure that each part D eligible individual has: (1) a choice of enrollment in a comprehensive prescription drug plan in the area in which the individual resides; or (2) in any case in which such a plan is not available, the opportunity to enroll in a comprehensive fallback prescription drug plan. | Health | Drug Coverage and Cost | Health | 2010-12-10 | needed drugs act directs comptroller general review report congress retail cost prescription drugs united_states emphasis prescription drugs utilized individuals age older requires comptroller general conduct ongoing study compares average retail cost united_states utilized prescription drugs individuals age older average prices private health plans department_of_defense dod defense_health_program department_of_veterans_affairs acquire drug average negotiated price drug eligible beneficiaries access medicare prescription drug plan providing basic prescription drug coverage amends title xviii medicare social security act ssa include comparative plan information beneficiaries medicare voluntary prescription drug benefit program comparison average aggregate prescription drug plan beneficiary costs savings costs beneficiary prescription drug plan repeals prohibition interference secretary health_and_human_services hhs negotiations drug manufacturers pharmacies prescription drug plan sponsors authorizes secretary instead like federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs requires use resulting savings strengthen program reduce federal deficit requires secretary ensure eligible individual choice enrollment comprehensive prescription drug plan area individual resides case plan available opportunity enroll comprehensive fallback prescription drug plan |
112-HR-171 | Health Care Tax Deduction Act of 2011 - Amends the Internal Revenue Code to allow individuals a tax deduction from gross income for health insurance premiums and unreimbursed prescription drug expenses paid for the benefit of the taxpayer and the taxpayer's spouse and dependents. | Health | Drug Coverage and Cost | Taxation | 2011-01-05 | amends internal revenue code allow individuals tax deduction gross income health insurance premiums unreimbursed prescription drug expenses paid benefit taxpayer taxpayer spouse dependents |
112-HR-524 | Restoring Consumer-driven Health Care Act of 2011 - Repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that: (1) limit payments from health and medical savings accounts and health flexible spending arrangements solely to medications that are prescribed drugs or insulin, and (2) increase taxes on distributions from health and medical savings accounts that are not used for qualified medical expenses. | Health | Drug Coverage and Cost | Taxation | 2011-02-08 | health care act repeals provisions internal_revenue_code added patient_protection affordable care act limit payments health medical savings accounts health flexible spending arrangements solely medications prescribed drugs insulin increase taxes distributions health medical savings accounts qualified medical expenses |
112-HR-892 | Stop Asian Carp Act - Directs the Secretary of the Army, acting through the Chief of Engineers, to study the watersheds of the Illinois, Chicago, and Calumet Rivers, including their tributaries, that drain directly into Lake Michigan to determine the feasibility and best means of implementing the hydrologic separation of the Great Lakes and the Mississippi River Basins to prevent the introduction or establishment of populations of aquatic nuisance species between the Great Lakes and Mississippi River Basins through the Chicago Area Water System (CAWS) and other aquatic pathways.Requires the study to: (1) include options to address flooding, Chicago wastewater and stormwater infrastructure, waterway safety operations, and barge and recreational vessel traffic alternatives; and (2) contain a detailed analysis of the environmental benefits and costs of each option.Directs: (1) the Secretary to carry out this Act at full federal cost; and (2) the President, or the Council on Environmental Quality as a designee to the President, to oversee the study to ensure its thoroughness and timely completion.Requires the Director of the United States Geological Survey (USGS), in cooperation with the Director of the United States Fish and Wildlife Service, to: (1) monitor and survey all waters that connect to the Great Lakes Basin or could connect to it due to flooding, underground hydrological connection, or human-made diversion to identify additional threats that could allow Asian Carp to enter the Basin; and (2) prioritize each threat and help identify means to impede the passage of Asian Carp to the Basin. | Health | Drug Coverage and Cost | Water resources development | 2011-03-03 | stop asian carp act directs secretary army acting chief engineers study watersheds illinois chicago including tributaries drain directly lake michigan determine feasibility best means implementing hydrologic separation great lakes mississippi_river_basins prevent introduction establishment populations aquatic nuisance species great_lakes mississippi_river_basins caws aquatic pathways requires study include options address flooding chicago wastewater stormwater infrastructure waterway safety operations barge recreational vessel traffic alternatives contain detailed analysis environmental benefits costs option directs secretary carry act federal cost president council_on_environmental_quality designee president oversee study ensure timely completion requires director united_states_geological_survey usgs cooperation director united_states fish_and_wildlife_service monitor survey waters connect great_lakes_basin connect flooding underground hydrological connection human diversion identify additional threats allow enter basin prioritize threat help identify means impede passage asian carp basin |
112-HR-906 | Positive Reduction of Incarceration by Maximizing Education Act or PRIME Act - Directs the Attorney General, through the Director of the Office of Juvenile Justice and Delinquency Prevention, to establish national, regional, and local public awareness campaigns focused on promoting the advantages of continued education among youth. | Health | Drug Coverage and Cost | Education | 2011-03-03 | positive reduction incarceration maximizing education act prime act directs attorney general director office_of_juvenile_justice delinquency_prevention establish national regional local public awareness campaigns focused promoting advantages continued education youth |
112-HR-979 | FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with the requirements for PBM carrier arrangements set forth by this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply with such requirements. Prohibits: (1) a PBM under a carrier arrangement from being under common corporate control with a prescription drug manufacturer or a retail pharmacy, and (2) OPM from permitting a carrier under common corporate control with a PBM to earn a profit from such control. Sets forth terms and requirements for PBM carrier arrangements under the FEHBP, including: (1) drug substitution restrictions, (2) PBM reimbursement of carriers, (3) sale by a PBM of utilization and claims data, (4) drug pricing and the basis for reimbursement, (5) PBM provision to plan enrollees of an explanation of benefits statement regarding prescription drugs, (6) nondiscriminatory contracts regarding required participation, (7) OPM access to PBM contract information, and (8) civil monetary penalties for making false statements or claims to the government. | Health | Drug Coverage and Cost | Government operations and politics | 2011-03-09 | fehbp prescription drug integrity transparency cost savings act prohibits entering contract approving health benefits plan carrier party pharmacy benefit manager pbm carrier arrangement provide administer prescription drug coverage federal_employees_health_benefits_program fehbp pbm carrier comply requirements pbm carrier arrangements set forth act directs opm terminate contract discontinue plan fails comply requirements prohibits pbm carrier arrangement common corporate control prescription drug manufacturer retail pharmacy opm permitting carrier common corporate control pbm earn profit control sets forth terms requirements pbm carrier arrangements fehbp including drug substitution restrictions pbm reimbursement carriers sale pbm utilization claims data drug pricing basis reimbursement pbm provision plan enrollees explanation benefits statement prescription drugs nondiscriminatory contracts required participation opm access pbm contract information civil monetary penalties making false statements claims government |
112-HR-989 | Voluntary State Discount Prescription Drug Plan Act of 2011 - Amends title XIX (Medicaid) of the Social Security Act to require drug manufacturers to pay rebates to state prescription drug discount programs as a condition of participating in a Medicaid rebate agreement for outpatient prescription drugs, but only if the state has elected to establish an optional state prescription drug discount program. | Health | Drug Coverage and Cost | Health | 2011-03-09 | plan act amends title xix medicaid social security act require drug manufacturers pay rebates state prescription drug discount programs condition participating medicaid rebate agreement outpatient prescription drugs state elected establish optional state prescription drug discount program |
112-HR-999 | Medicare Prescription Drug Savings and Choice Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; and (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan. | Health | Drug Coverage and Cost | Health | 2011-03-10 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan |
112-HR-1055 | Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature. | Health | Drug Coverage and Cost | Health | 2011-03-11 | label prescription parity act amends voluntary prescription drug benefit program title xviii medicare social security act permit prescription drug plan pdp sponsor offering pdp medicareadvantage organization offering ma-pd plan offer coverage covered drugs uses determined medically accepted indications based guidance provided secretary health_and_human_services hhs determining accepted uses covered drugs supportive clinical evidence peer reviewed medical literature |
112-HR-1406 | Fairness to Pet Owners Act of 2011 - Requires the Federal Trade Commission (FTC) to promulgate rules relating to veterinary prescriptions, including rules requiring the prescriber of an animal drug to: (1) provide the pet owner a copy of the veterinary prescription and a written disclosure that the pet owner may fill the prescription through the prescriber (if available) or through another pharmacy determined by the pet owner; and (2) provide or verify the prescription by electronic or other means consistent with applicable state law, if requested by any person designated to act on behalf of the pet owner. Prohibits the prescriber of an animal drug from setting conditions on providing a copy of the prescription or verifying such prescription by: (1) requiring the purchase of the drug from the prescriber or from another person; (2) requiring payment in addition to, or as part of, the fee for an examination and evaluation; or (3) requiring the pet owner to sign a waiver or disclaim liability of the prescriber for the accuracy of the veterinary prescription, or delivering to the pet owner a notice waiving or disclaiming such liability. Permits the prescriber to require payment of fees for an examination and evaluation before providing a veterinary prescription, but only if the prescriber requires immediate payment in the case of an examination that reveals no requirement for an animal drug. | Health | Drug Coverage and Cost | Commerce | 2011-04-06 | fairness pet owners act requires federal_trade_commission ftc promulgate rules relating veterinary prescriptions including rules requiring prescriber animal drug provide pet owner copy veterinary prescription written disclosure pet owner fill prescription prescriber available pharmacy determined pet owner provide verify prescription electronic means consistent applicable state law requested person designated act behalf pet owner prohibits prescriber animal drug setting conditions providing copy prescription verifying prescription requiring purchase drug prescriber person requiring payment addition fee examination evaluation requiring pet owner sign waiver liability prescriber accuracy veterinary prescription delivering pet owner notice waiving liability permits prescriber require payment fees examination evaluation providing veterinary prescription prescriber requires immediate payment case examination reveals requirement animal drug |
112-HR-2190 | Medicare Drug Savings Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require drug manufacturers to pay the Secretary of Health and Human Services (HHS) drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary. Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2011, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan (PDP) sponsor or MedicareAdvantage (MA) organization for such period. Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals. Amends SSA title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program. | Health | Drug Coverage and Cost | Health | 2011-06-15 | medicare_drug_savings_act amends voluntary prescription drug benefit program title xviii medicare social security act ssa require drug manufacturers pay secretary health_and_human_services hhs drug rebates rebate eligible low income individuals excludes medicare coverage drug drug biological manufactured manufacturer entered effect rebate agreement secretary requires rebate agreement require drug biological manufacturer provide secretary rebate determined according specified formula rebate period ending december covered medicare drug dispensed date rebate eligible individual payment prescription drug plan pdp sponsor medicareadvantage organization period specifies formula determination medicaid rebate amounts drugs biologicals amends ssa title xix medicaid exclude amounts paid rebate agreement determination best price average manufacturer price medicaid program |
112-HR-2248 | Medicare Prescription Drug Price Negotiation Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2011-06-21 | medicare prescription drug price negotiation act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services hhs negotiate pharmaceutical manufacturers prices charged medicare prescription drug plan pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan |
112-HR-2296 | America Rx Act of 2011 - Requires the Secretary of Health and Human Services (HHS) to establish the America Rx program to provide qualified residents with access to discounted prices for outpatient prescription drugs through rebate agreements that the Secretary negotiates with prescription drug manufacturers. Makes eligible only those residents that are not covered under any public or private program that provides substantial benefits towards the purchase of outpatient prescription drugs. Requires rebates to be payable to the Secretary at least quarterly and to be paid, directly or through states, to participating pharmacies that provide discounts to qualified residents. Denies manufacturers who do not participate in the rebate program a tax deduction for advertising and marketing expenses of drugs. Authorizes the Secretary to suspend or terminate the America Rx program if the Secretary determines that American Health Benefit Exchanges (health insurance exchanges) are operational, and the America Rx program is no longer needed to ensure that qualified residents have access to outpatient prescription drugs at affordable prices. | Health | Drug Coverage and Cost | Health | 2011-06-22 | america act requires secretary health_and_human_services hhs establish america program provide qualified residents access discounted prices outpatient prescription drugs rebate agreements secretary prescription drug manufacturers makes eligible residents covered public private program provides substantial benefits purchase outpatient prescription drugs requires rebates payable secretary quarterly paid directly states participating pharmacies provide discounts qualified residents denies manufacturers participate rebate program tax deduction advertising marketing expenses drugs authorizes secretary suspend terminate america program secretary determines health insurance exchanges operational america program longer needed ensure qualified residents access outpatient prescription drugs affordable prices |
112-HR-2674 | 340B Program Improvement Act - Amends the Public Health Service Act to make revisions to the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees). Includes drugs used in connection with an inpatient or outpatient service by enrolled hospitals as covered drugs under the program (currently, only outpatient drugs are covered under the program). Requires hospitals enrolled in the 340B program to provide to each state a credit on the estimated annual purchases by such hospitals of covered drugs provided to Medicaid recipients for inpatient use. Sets forth a formula for calculating the credit. Allows a hospital to avoid paying such credits under certain circumstances. Eliminates the requirement that hospitals enrolled in the 340B program report the National Drug Code numbers for drugs administered by a physician if the state is precluded from seeking a rebate on such drugs because they were purchased at a discount under the 340B program. Removes the exclusion that prohibited covered entities added to the 340B program under the Patient Protection and Affordable Care Act from purchasing drugs for a rare disease or condition as covered outpatient drugs. Treats a facility or organization that is eligible for the 340B program as satisfying any geographic location requirements in relation to a hospital or a critical access hospital for purposes of determining provider-based status under Medicare. | Health | Drug Coverage and Cost | Health | 2011-07-27 | revisions 340b drug discount program program limiting cost covered outpatient drugs certain federal grantees includes drugs connection inpatient outpatient service enrolled hospitals covered drugs program currently outpatient drugs covered program requires hospitals enrolled 340b program provide state credit estimated annual purchases hospitals covered drugs provided medicaid recipients inpatient use sets forth formula calculating credit allows hospital avoid paying credits certain circumstances eliminates requirement hospitals enrolled 340b program report national drug code numbers drugs administered physician state precluded seeking rebate drugs purchased discount 340b program removes exclusion prohibited covered entities added 340b program patient_protection affordable care act purchasing drugs rare disease condition covered outpatient drugs treats facility organization eligible 340b program satisfying geographic location requirements relation hospital critical access hospital purposes determining provider based status medicare |
112-HR-2969 | Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 - Amends title II (Old Age, Survivors and Disability Benefits) (OASDI) of the Social Security Act (SSA) to extend the months of coverage of immunosuppressive drugs for kidney transplant patients. Amends SSA title XVIII (Medicare) to make eligible for enrollment in Medicare part B (Supplementary Medical Insurance), solely for the purpose of such drug coverage, every individual whose insurance benefits under Medicare part A (Hospital Insurance) have ended by reason of a kidney transplant or the end of any requirement for a regular course of dialysis. Directs the Secretary of Health and Human Services (HHS) to determine a monthly premium rate for such individuals equal to 35% of the monthly actuarial rate for enrollees age 65 and over. Prescribes a formula for detemination of a government contribution to such a premium. | Health | Drug Coverage and Cost | Health | 2011-09-20 | comprehensive immunosuppressive drug coverage kidney transplant patients act amends title old age survivors disability benefits oasdi social security act ssa extend months coverage immunosuppressive drugs kidney transplant patients amends ssa title xviii medicare eligible enrollment medicare supplementary_medical_insurance solely purpose drug coverage individual insurance benefits medicare ended reason kidney transplant end requirement regular course dialysis directs secretary health_and_human_services hhs determine monthly premium rate individuals equal monthly actuarial rate enrollees age prescribes formula government contribution premium |
112-HR-3613 | Part D Beneficiary Appeals Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act, with respect to a prescription drug plan (PDP) that provides for any tiered cost-sharing within a formulary (including a structure that provides for different co-payment or coinsurance amounts for drugs in different tiers included within the formulary), to authorize a Medicare part D eligible individual enrolled in the plan to request an exception to the tiered cost-sharing structure. States that in no case may the Secretary of Health and Human Services (HHS) allow a PDP sponsor to make any element of the tiered cost-sharing structure (including a tier used for very high cost or unique items) ineligible for lower-cost sharing through an exception. | Health | Drug Coverage and Cost | Health | 2011-12-08 | beneficiary appeals fairness act amends voluntary prescription drug benefit program title xviii medicare social security act respect prescription drug plan pdp provides tiered cost sharing formulary including structure provides different payment coinsurance amounts drugs different tiers included formulary authorize medicare eligible individual enrolled plan request exception tiered cost sharing structure states case secretary health_and_human_services hhs allow pdp sponsor element tiered cost sharing structure including tier high cost unique items ineligible lower cost sharing exception |
112-HR-4209 | Patients' Access to Treatments Act of 2012 - Amends the Public Health Service Act to prohibit a health plan offering group or individual health insurance that provides coverage for prescription drugs and uses a formulary or other tiered cost-sharing structure from imposing co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of such requirements applicable to prescription drugs in a non-preferred brand drug tier. Provides that if a formulary used by such a health plan contains more than one non-preferred brand drug tier, such prohibition shall be applied with respect to the non-preferred brand drug tier for which beneficiary cost-sharing is lowest. Defines: (1) "non-preferred brand drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs in the plan's formulary, that are prescription drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of drugs within a tier in such formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary and that are prescription drugs. | Health | Drug Coverage and Cost | Health | 2012-03-19 | patients access treatments act amends public_health_service_act prohibit health plan offering group individual health insurance provides coverage prescription drugs uses formulary tiered cost sharing structure imposing payment coinsurance cost sharing requirements applicable prescription drugs specialty drug tier exceed dollar requirements applicable prescription drugs non preferred brand drug tier provides formulary health plan contains non preferred brand drug tier prohibition shall applied respect non preferred brand drug tier beneficiary cost sharing lowest defines non preferred brand drug tier category drugs tier formulary beneficiary cost sharing greater tiers generic drugs preferred brand drugs plan formulary prescription drugs included specialty drug tier specialty drug tier category drugs tier formulary beneficiary cost sharing greater tiers generic drugs preferred brand drugs non preferred drugs plan formulary prescription drugs |
112-HR-4215 | Medicare Pharmacy Transparency and Fair Auditing Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each contract entered into with a prescription drug plan (PDP) sponsor for the offering of a prescription drug plan to prohibit the PDP sponsor from contracting with any pharmacy benefits manager (PBM) to manage the prescription drug coverage under such plan, or to control the costs of such coverage, unless the manager satisfies specified PBM audit and disclosure requirements. | Health | Drug Coverage and Cost | Health | 2012-03-20 | fair auditing act amends voluntary prescription drug benefit program title xviii medicare social security act require contract entered prescription drug plan pdp sponsor offering prescription drug plan prohibit pdp sponsor contracting pharmacy benefits manager pbm manage prescription drug coverage plan control costs coverage manager satisfies specified pbm audit disclosure requirements |
112-HR-6392 | Negotiating for Seniors Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to repeal the prohibition against: (1) interference by the Secretary of Health and Human Services (HHS) with the negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, and (2) the Secretary's requiring a particular formulary or instituting a price structure for the reimbursement of covered Medicare part D drugs. | Health | Drug Coverage and Cost | Health | 2012-09-13 | negotiating seniors act amends voluntary prescription drug benefit program title xviii medicare social security act repeal prohibition interference secretary health_and_human_services hhs negotiations drug manufacturers pharmacies prescription drug plan sponsors secretary requiring particular formulary instituting price structure reimbursement covered medicare drugs |
112-HR-6433 | FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs. Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees. | Health | Drug Coverage and Cost | Health | 2012-09-19 | fda user fee corrections act amends cosmetic act ffdca amended innovation_act clerical corrections provisions act eliminate restriction appropriated funds shall available payment increases cost reviewing medical device applications including related personnel costs specifies dates fy2013 ffdca drug master file fee abbreviated new drug application prior approval supplement filing fees generic drug facility active pharmaceutical ingredient facility fees |
112-S-31 | Prescription Drug and Health Improvement Act of 2011 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to prescription drug plans to repeal the prohibition against: (1) interference by the Secretary of Health and Human Services (HHS) with negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors, and (2) requiring a particular formulary or instituting a price structure for the reimbursement of covered part D (Voluntary Prescription Drug Benefit Program) drugs. Grants the Secretary authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs. | Health | Drug Coverage and Cost | Health | 2011-01-25 | prescription drug health improvement act amends title xviii medicare social security act ssa respect prescription drug plans repeal prohibition interference secretary health_and_human_services hhs negotiations drug manufacturers pharmacies prescription drug plan sponsors requiring particular formulary instituting price structure reimbursement covered voluntary prescription drug benefit program drugs grants secretary authority similar federal entities purchase prescription drugs bulk negotiate contracts manufacturers covered drugs |
112-S-44 | Medicare Prescription Drug Price Negotiation Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug (MA-PD) plan. | Health | Drug Coverage and Cost | Health | 2011-01-25 | medicare prescription drug price negotiation act amends voluntary prescription drug benefit program title xviii medicare social security act direct secretary health_and_human_services hhs negotiate pharmaceutical manufacturers prices charged medicare prescription drug plan pdp sponsors medicareadvantage organizations covered drugs eligible individuals enrolled pdp ma-prescription_drug ma-pd plan |
112-S-560 | Medicare Prescription Drug Savings and Choice Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to provide for: (1) establishment of one or more Medicare operated prescription drug plan options; and (2) an appeals process for denials of benefits under a Medicare operated prescription drug plan. | Health | Drug Coverage and Cost | Health | 2011-03-10 | medicare_prescription_drug_savings choice act amends voluntary prescription drug benefit program title xviii medicare social security act provide establishment medicare operated prescription drug plan options appeals process denials benefits medicare operated prescription drug plan |
112-S-733 | Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers. | Health | Drug Coverage and Cost | Health | 2011-04-05 | amends supplementary_medical_insurance title xviii medicare social security act exclude average sales price calculating medicare payments drugs biologicals customary prompt pay discounts manufacturers wholesalers |
112-S-882 | Stop Trafficking of Pills Act or STOP Act - Amends title XIX (Medicaid) of the Social Security Act (SSA) to require state Medicaid plans to: (1) identify prescription drugs that present a high-risk of misuse or overutilization, (2) establish a dosage level for each such drug that would be deemed excessive in the absence of evidence of medical necessity, (3) identify Medicaid-eligible individuals who are either receiving a prescription drug at excessive dosage levels or who have been convicted of a drug-related offense, and (4) ensure that they are assigned to a state-established restricted recipient program. Requires a state to establish a Medicaid Lock-in Program to ensure that a high-risk prescription drug user is assigned to: (1) a single and exclusive physician for purposes of receiving any medical assistance related to a prescription drug, and (2) a single and exclusive pharmacy to receive any physician-prescribed drug. Requires a state to establish a Medicaid prescription drug restriction program to ensure that the state claims processing system does not permit a prescription drug to be dispensed to a high-risk prescription drug user more than once every 20 days. Amends part D (Miscellaneous) of SSA title XXVIII (Medicare) to direct the Secretary of Health and Human Services (HHS) to establish a similar restricted recipient program for high-risk prescription drug users under the Medicare program. | Health | Drug Coverage and Cost | Health | 2011-05-04 | stop trafficking act stop act amends title xix medicaid social security act ssa require state medicaid plans identify prescription drugs present high risk misuse establish dosage level drug deemed excessive absence evidence medical necessity identify medicaid eligible individuals receiving prescription drug excessive dosage levels convicted drug related offense ensure assigned state established restricted recipient program requires state establish program ensure high risk prescription drug user assigned single exclusive physician purposes receiving medical assistance related prescription drug single exclusive pharmacy receive physician prescribed drug requires state establish medicaid prescription drug restriction program ensure state claims processing system permit prescription drug dispensed high risk prescription drug user days amends miscellaneous ssa title medicare direct secretary health_and_human_services hhs establish similar restricted recipient program high risk prescription drug users medicare program |
112-S-1138 | Prize Fund for HIV/AIDS Act - Prohibits any person from having the right to exclusively manufacture, distribute, sell, or use in interstate commerce a qualifying treatment for HIV/AIDS or a manufacturing process for such a treatment, including the exclusive right to rely on health registration data or the 30-month stay-of-effectiveness period for Orange Book patents, notwithstanding provisions of U.S. patent law and other relevant statutes. Establishes remuneration in lieu of such market exclusivity. Makes the elimination of exclusive rights for a product that is a qualifying treatment for HIV/AIDS and that has a significant use for other diseases (dual use products) applicable only with respect to the marketing, distribution, sale, or use of a qualifying treatment for HIV/AIDS or a manufacturing process for such treatment that occurs on or after October 1, 2012. Establishes the Prize Fund for HIV/AIDS. Requires the Secretary of Health and Human Services (HHS) to designate a Prize Fund Director to administer the Fund. Directs the Prize Fund Director to award prize payments for medical innovation relating to a qualifying treatment for HIV/AIDS or a new manufacturing process for such a treatment to: (1) the first person to receive market clearance with respect to the drug or biological product; (2) the holder of the patent with respect to a manufacturing process; or (3) in the case of open source contributions, the persons or communities that openly shared knowledge, data, materials, and technology on a royalty-free and nondiscriminatory basis. Allows the Prize Fund Director to authorize multiple nonprofit intermediaries to manage Fund payments to reward projects for: (1) interim research and development of new qualifying treatments for HIV/AIDS, or (2) open source dividend prizes Sets forth transitional rules. Establishes an annual fee for health insurers to fund this Act. Establishes the Donor Innovation Prize Fund to enable the Secretary to reward owners and developers of products that permit open competition for products in developing countries. | Health | Drug Coverage and Cost | Health | 2011-05-26 | prize fund hiv aids act prohibits person having right exclusively manufacture distribute sell use interstate commerce qualifying treatment hiv aids manufacturing process treatment including exclusive right rely health registration data month stay effectiveness period patents notwithstanding provisions patent law relevant statutes establishes remuneration lieu market exclusivity makes elimination exclusive rights product qualifying treatment hiv aids significant use diseases dual use products applicable respect marketing distribution sale use qualifying treatment hiv aids manufacturing process treatment occurs october establishes prize fund hiv aids requires secretary health_and_human_services hhs designate director administer fund directs prize fund director award prize payments medical innovation relating qualifying treatment hiv aids new manufacturing process treatment person receive market clearance respect drug biological product holder patent respect manufacturing process case open source contributions persons communities openly shared knowledge data materials technology royalty free nondiscriminatory basis allows prize fund director authorize multiple nonprofit intermediaries manage fund payments reward projects interim research development new qualifying treatments hiv aids open source dividend prizes sets forth transitional rules establishes annual fee health insurers fund act establishes donor innovation prize fund enable secretary reward owners developers products permit open competition products developing countries |
112-S-1206 | Medicare Drug Savings Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require drug manufacturers to pay the Secretary of Health and Human Services (HHS) drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary. Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2011, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan (PDP) sponsor or MedicareAdvantage (MA) organization for such period. Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals. Amends SSA title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program. | Health | Drug Coverage and Cost | Health | 2011-06-15 | medicare_drug_savings_act amends voluntary prescription drug benefit program title xviii medicare social security act ssa require drug manufacturers pay secretary health_and_human_services hhs drug rebates rebate eligible low income individuals excludes medicare coverage drug drug biological manufactured manufacturer entered effect rebate agreement secretary requires rebate agreement require drug biological manufacturer provide secretary rebate determined according specified formula rebate period ending december covered medicare drug dispensed date rebate eligible individual payment prescription drug plan pdp sponsor medicareadvantage organization period specifies formula determination medicaid rebate amounts drugs biologicals amends ssa title xix medicaid exclude amounts paid rebate agreement determination best price average manufacturer price medicaid program |
End of preview. Expand
in Dataset Viewer.
Dataset Overview
This repository contains benchmark datasets for evaluating Large Language Model (LLM)-based topic discovery methods and comparing them against traditional topic models. These datasets provide a valuable resource for researchers studying topic modeling and LLM capabilities in this domain. The work is described in the following paper: Large Language Models Struggle to Describe the Haystack without Human Help: Human-in-the-loop Evaluation of LLMs. Original data source: GitHub
Bills Dataset
The Bills Dataset is a collection of legislative documents containing 32,661 bill summaries (train) from the 110th–114th U.S. Congresses, categorized into 21 top-level and 112 secondary-level topics. A test split of 15.2K summaries is also included.
Loading the Bills Dataset
from datasets import load_dataset
# Load the train and test splits
train_dataset = load_dataset('zli12321/Bills', split='train')
test_dataset = load_dataset('zli12321/Bills', split='test')
Wiki Dataset
The Wiki dataset consists of 14,290 articles spanning 15 high-level and 45 mid-level topics, including widely recognized public topics such as music and anime. A test split of 8.02K summaries is included.
Synthetic Science Fiction (Pending internal clearance process)
Please cite the relevant papers below if you find the data useful. Do not hesitate to create an issue or email us if you have problems!
Citation:
If you find LLM-based topic generation has hallucination or instability, and coherence not applicable to LLM-based topic models:
@misc{li2025largelanguagemodelsstruggle,
title={Large Language Models Struggle to Describe the Haystack without Human Help: Human-in-the-loop Evaluation of LLMs},
author={Zongxia Li and Lorena Calvo-Bartolomé and Alexander Hoyle and Paiheng Xu and Alden Dima and Juan Francisco Fung and Jordan Boyd-Graber},
year={2025},
eprint={2502.14748},
archivePrefix={arXiv},
primaryClass={cs.CL},
url={https://arxiv.org/abs/2502.14748},
}
If you use the human annotations or preprocessing:
@inproceedings{li-etal-2024-improving,
title = "Improving the {TENOR} of Labeling: Re-evaluating Topic Models for Content Analysis",
author = "Li, Zongxia and
Mao, Andrew and
Stephens, Daniel and
Goel, Pranav and
Walpole, Emily and
Dima, Alden and
Fung, Juan and
Boyd-Graber, Jordan",
editor = "Graham, Yvette and
Purver, Matthew",
booktitle = "Proceedings of the 18th Conference of the European Chapter of the Association for Computational Linguistics (Volume 1: Long Papers)",
month = mar,
year = "2024",
address = "St. Julian{'}s, Malta",
publisher = "Association for Computational Linguistics",
url = "https://aclanthology.org/2024.eacl-long.51/",
pages = "840--859"
}
If you want to use the claim coherence does not generalize to neural topic models:
@inproceedings{hoyle-etal-2021-automated,
title = "Is Automated Topic Evaluation Broken? The Incoherence of Coherence",
author = "Hoyle, Alexander Miserlis and
Goel, Pranav and
Hian-Cheong, Andrew and
Peskov, Denis and
Boyd-Graber, Jordan and
Resnik, Philip",
booktitle = "Advances in Neural Information Processing Systems",
year = "2021",
url = "https://arxiv.org/abs/2107.02173",
}
If you evaluate ground-truth evaluations or stability:
@inproceedings{hoyle-etal-2022-neural,
title = "Are Neural Topic Models Broken?",
author = "Hoyle, Alexander Miserlis and
Goel, Pranav and
Sarkar, Rupak and
Resnik, Philip",
booktitle = "Findings of the Association for Computational Linguistics: EMNLP 2022",
year = "2022",
publisher = "Association for Computational Linguistics",
url = "https://aclanthology.org/2022.findings-emnlp.390",
doi = "10.18653/v1/2022.findings-emnlp.390",
pages = "5321--5344",
}
- Downloads last month
- 116